CurrentRheuma
Get Weekly

Topic · page 16 of 17

Osteoporosis & bone health

Postmenopausal, male and glucocorticoid-induced osteoporosis, fracture risk assessment and bone density, fragility fractures and their secondary prevention, anti-resorptive and anabolic drugs, treatment sequence and drug holidays

Briefs 601–640 of 659 placed here, newest publication first

Briefs in Osteoporosis & bone health

Newest publication first

  1. Osteoporos Int

    Ethnic disparities in fracture risk assessment using polygenic scores

    Cohort study

  2. Osteoporos Int

    Risk of developing age-related macular degeneration in patients with osteoporosis: a population-based, longitudinal follow-up study

    Cohort study

  3. Osteoporos Int

    International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures

    Guideline or statement

  4. Osteoporos Int

    Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study

    Cohort study

  5. RMD Open

    Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population: a register-based study from Sweden

    Cohort study

  6. Osteoporos Int

    Lower incidence of hip fractures among elderly Ethiopian immigrants to Israel: first assessment from the Israel National Trauma Registry (INTR) 2011–2020

    Cohort study

  7. Osteoporos Int

    A nomogram for predicting residual low back pain after percutaneous kyphoplasty in osteoporotic vertebral compression fractures

    Cohort study

  8. Osteoporos Int

    Prevalence of osteoporosis and incidence of related fractures in developed economies in the Asia Pacific region: a systematic review

    Meta-analysis

  9. Osteoporos Int

    National trends in osteoporosis medication use among Medicare beneficiaries with and without Alzheimer’s disease/related dementias

    Cohort study

  10. Osteoporos Int

    Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event

    Cohort study

  11. JAMA Netw Open

    Comparison of Fractures Among Older Adults Who Are Ambulatory vs Those Who Use Wheelchairs in Sweden

    Cohort study

  12. Osteoporos Int

    Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017–2018

    Cross-sectional study

  13. Osteoporos Int

    Prevention of aromatase inhibitor–induced bone loss with anti-resorptive therapy in post-menopausal women with early-stage breast cancer

    Cohort study

  14. Osteoporos Int

    The healthcare system costs of hip fracture care in South Africa

    Cohort study

  15. Osteoporos Int

    Implementation and operationalization of Integrated People-Centred Health Services delivery strategies in integrated osteoporosis care (IOC) initiatives: a systematic review

    Meta-analysis

  16. Osteoporos Int

    Follicle-stimulating hormone is associated with low bone mass in postmenopausal women

    Cross-sectional study

  17. Osteoporos Int

    A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis

    Guideline or statement

  18. Osteoporos Int

    The clinical utility of the BMD-related comprehensive genome-wide polygenic score in identifying individuals with a high risk of osteoporotic fractures

    Cohort study

  19. Osteoporos Int

    Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort study

    Cohort study

  20. Osteoporos Int

    A 3-year retrospective analysis of patients admitted with clinical vertebral fragility fractures across hospitals in England, UK

    Cohort study

  21. Osteoporos Int

    Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study

    Cohort study

  22. Osteoporos Int

    Are there specific clinical risk factors for the occurrence of multiple fractures? The FRISBEE study

    Cohort study

  23. Osteoporos Int

    The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review

    Research article

  24. Osteoporos Int

    Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice

    Meta-analysis

  25. Ann Intern Med

    Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians

    Meta-analysis

  26. Ann Intern Med

    Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians

    Guideline or statement

  27. Osteoporos Int

    Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis

    Cohort study

  28. Osteoporos Int

    Prevalence of osteoporosis in older male veterans receiving hip-containing computed tomography scans: opportunistic use of biomechanical computed tomography analysis (BCT)

    Cross-sectional study

  29. Osteoporos Int

    C-reactive protein predicts endocortical expansion but not fracture in older men: the prospective STRAMBO study

    Cohort study

  30. Osteoporos Int

    Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year

    Cohort study

  31. Osteoporos Int

    Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption

    Secondary analysis

  32. Joint Bone Spine

    Dietary recommendations in the prevention and treatment of osteoporosis

    Guideline or statement

  33. Osteoporos Int

    A systematic review of cost‑effectiveness analyses of sequential treatment for osteoporosis

    Meta-analysis

  34. Osteoporos Int

    Primary hyperparathyroidism and fracture probability

    Cohort study

  35. Osteoporos Int

    The high-risk hip fracture patient and the palliative care consult : A retrospective study to investigate risks of complications and the utility of a palliative care consult in hip fracture patients undergoing surgical fixation

    Cohort study

  36. Osteoporos Int

    Frailty and risk of subsequent fracture among older adults presenting to hospital with a minimal trauma fracture

    Cohort study

  37. Osteoporos Int

    Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019

    Cohort study

  38. Osteoporos Int

    Variation in bone mineral density and fractures over 20 years among Canadians: a comparison of the Canadian Multicenter Osteoporosis Study and the Canadian Longitudinal Study on Aging

    Cohort study

  39. Osteoporos Int

    Fracture liaison service model: project design and accreditation

    Research article

  40. Osteoporos Int

    A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients

    Cohort study

All 659 Briefs in ExploreShowing Briefs 601–640 of 659, newest first